Pre-market hot trades in the US stock market: Presidio Property Trust up 10.96% in pre-market; Upexi down 7.02% in pre-market

Tracking Unusual Activity
2025.08.14 12:37
portai
I'm PortAI, I can summarize articles.

Presidio Property Trust pre-market up 10.96%; Upexi pre-market down 7.02%; Expion360 pre-market up 186.26%; Sonoma Pharmaceuticals pre-market up 98.56%; Aeries Tech pre-market up 52.86%

Pre-market Hot Trades in US Stocks

Presidio is up 10.96% in pre-market trading. Based on recent important news:

  1. On July 15, Presidio announced the purchase of 170,830 shares at $12.00 per share, demonstrating the company's confidence in its own stock, which drove the share price up.

  2. On July 9, Presidio updated its model home activities, which may trigger market optimism regarding its business growth, further boosting the share price.

  3. On June 13, CEO Jack Kendrick Heilbron increased his holdings in the company's common stock, enhancing market confidence and pushing the share price higher.

Upexi is down 7.02% in pre-market trading. According to recent important news:

  1. On August 12, Upexi announced that BitMEX co-founder Arthur Hayes joined the advisory board to drive strategic development and market exposure. However, the market reacted negatively to this news, leading to a 7.02% drop in the share price.

Top Gainers in Pre-market US Stocks

Expion360 is up 186.26% in pre-market trading. Based on recent important news:

  1. On August 13, Expion360 released its Q2 2025 financial report, showing a 134% year-over-year increase in GAAP revenue to $3 million, and a 38% improvement in net loss to $1.4 million, driving the share price significantly higher.

  2. On August 13, the company's gross profit was $600,000, indicating an improvement in profitability, further boosting market confidence.

  3. On August 13, the CEO stated during the earnings call that the company has ample inventory and is expected to continue growing in the future, enhancing investor optimism.

Sonoma Pharmaceuticals is up 98.56% in pre-market trading. Based on recent important news:

  1. On August 5, Sonoma Pharmaceuticals projected a 19.4% increase in quarterly revenue, with analysts giving a "strong buy" rating and a target price 79.2% higher than the current price, driving the stock price up significantly.

  2. Recently, the chemical pharmaceutical sector has performed strongly, increasing investor confidence in the pharmaceutical industry's prospects, boosting Sonoma Pharmaceuticals' stock price.

  3. On August 6, Sonoma Pharmaceuticals is set to release its financial report, with market expectations optimistic, further stimulating the stock price increase.

AERT is up 52.86% in pre-market trading. Based on recent key news:

  1. On July 17, Aeries Technology announced it has restored compliance with Nasdaq's minimum bid listing requirements, leading to a significant increase in the stock price.

  2. On July 18, the company confirmed that it has fully resolved compliance issues without the need for hearings or appeals, further boosting market confidence.

  3. On July 3, the company strengthened cost control and deepened cooperation with North American private equity-supported enterprises, looking forward to growth prospects in 2026

Source: Tracking Unusual Activity The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.